Platelet growth factors - From the laboratory to the clinic

Diáne Hershock, Lynn M. Schuchter

Research output: Contribution to journalReview articlepeer-review

Abstract

Thrombocytopenia can be a life-threatening complication of hematologic disorders or it may be secondary to medical intervention with chemotherapy. The increased use of platelet transfusions to ameliorate the complications of thrombocytopenia carries increased patient risk from platelet transfusions due to alloimmunization, infection, and transfusion reactions. Recent advances in the understanding of platelet growth factors, including thrombopoietin, interleukin (IL)-3, IL-6, and IL-11 have shown that their clinical use may decrease platelet-transfusion requirements.

Original languageEnglish (US)
Pages (from-to)183-189
Number of pages7
JournalInfections in Medicine
Volume16
Issue number3
StatePublished - Jan 1 1999

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Platelet growth factors - From the laboratory to the clinic'. Together they form a unique fingerprint.

Cite this